[A program of intracavernous drug-induced erection for the treatment of impotence].
The study includes 138 patients with erectile dysfunction, all of them previously treated with intracavernous injections. Following study and classification of the type of impotence, they were all included in one of the four following groups. The drugs used were, in group I (73 patients) Prostaglandins E1, in group II (37 patients) Papaverine, in group III (6 patients) a combination of Papaverine and Phentolamine and in group IV (22 patients) a combination of Papaverine and Prostaglandins E1. We found a good treatment response in 59.3% cases (60.3% in group I, 51.3% in group II, 66.7% in group III, and 69% in group IV). We outline the better results obtained in group IV, as well as the reduced number of complications in our series.
Navío
S
S
Servicio de Urología, Hospital Ramón y Cajal.
Allona
A
A
Serrano
A
A
Vallejo
J
J
del Hoyo
J
J
Rivas
J A
JA
Escudero
A
A
D000287:Administration, Topical; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D004543:Ejaculatory Ducts; D007172:Erectile Dysfunction / Q000188:drug therapy*; D006801:Humans; D008297:Male; D010208:Papaverine / Q000008:administration & dosage; D010410:Penile Erection / Q000187:drug effects*; D010646:Phentolamine / Q000008:administration & dosage; D011458:Prostaglandins E / Q000008:administration & dosage; D012669:Seminal Vesicles / Q000187:drug effects
D011458:Prostaglandins E; D010208:Papaverine; D010646:Phentolamine